Literature DB >> 16308262

Euosmia: a rare form of parosmia.

B N Landis1, J Frasnelli, T Hummel.   

Abstract

The nature of qualitative olfactory disorders such as phantosmia and parosmia is a matter of debate. Parosmia and phantosmia mainly occur in combination with post-traumatic or post-infectious olfactory loss. Rare causes of these disorders such as brain tumors, side-effects of drugs, paraneoplastic syndromes, psychiatric disorders or intracerebral haemorrhage have been reported. Parosmias are distorted sensations of smell elicited by an odor, whereas phantosmias persist permanently or occur without the presence of an odor source. Phantosmias differ widely in terms of their nature. In contrast, parosmias always seem to be unpleasant. We report the case of a female with post-infectious hyposmia who reported a pleasant parosmia to selected odorants. We have called this rare clinical presentation euosmia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16308262     DOI: 10.1080/00016480510043954

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  6 in total

1.  Changes in smell and taste perception related to COVID-19 infection: a case-control study.

Authors:  Camilla Cattaneo; Ella Pagliarini; Sara Paola Mambrini; Elena Tortorici; Roberto Mené; Camilla Torlasco; Elisa Perger; Gianfranco Parati; Simona Bertoli
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

2.  Prevalence and correlates of parosmia and phantosmia among smell disorders.

Authors:  Robert Pellegrino; Joel D Mainland; Christine E Kelly; Jane K Parker; Thomas Hummel
Journal:  Chem Senses       Date:  2021-01-01       Impact factor: 3.160

3.  Delayed Parosmia Following SARS-CoV-2 Infection: a Rare Late Complication of COVID-19.

Authors:  Murat Duyan; Ibrahim Ulas Ozturan; Murat Altas
Journal:  SN Compr Clin Med       Date:  2021-03-27

4.  SCENTinel 1.1 rapidly screens for COVID-19 related olfactory disorders.

Authors:  Stephanie R Hunter; Mackenzie E Hannum; Robert Pellegrino; Maureen A O'Leary; Nancy E Rawson; Danielle R Reed; Pamela H Dalton; Valentina Parma
Journal:  medRxiv       Date:  2022-03-23

5.  Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.

Authors:  Joseph B Gary; Liam Gallagher; Paule V Joseph; Danielle Reed; David A Gudis; Jonathan B Overdevest
Journal:  Am J Rhinol Allergy       Date:  2022-08-11       Impact factor: 2.300

6.  Hidden consequences of olfactory dysfunction: a patient report series.

Authors:  Andreas Keller; Dolores Malaspina
Journal:  BMC Ear Nose Throat Disord       Date:  2013-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.